ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Short‐Course Subcutaneous Immunotherapy With Mannan‐Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements

Study limitation reported by the research below: “One grade III systemic allergic reaction (considered treatment-related) occurred among 186 active-treated participants; clinicians must have emergency management protocols in place for all SCIT administrations.”

Papers